EMERYVILLE, Calif., Aug. 24, 2011 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical-stage biotechnology company developing its first-in-class, anti-infective Aganocide® compounds for the local non-systemic treatment and prevention of antibiotic-resistant infections, announces that Ron Najafi, Ph.D., Chairman and Chief Executive Officer, will deliver a corporate presentation at The 2011 Southern California Investor Conference to be held at the Island Hotel Newport Beach on August 29, 2011. The presentation is scheduled for 10:30 AM PDT / 1:30 PM EDT, and a webcast can be accessed through the following link: http://events.powerstream.net/002/00623/20110829SCICnovaBay/
